"Clinical Trials as Topic" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Works about pre-planned studies of the safety, efficacy, or optimum dosage schedule (if appropriate) of one or more diagnostic, therapeutic, or prophylactic drugs, devices, or techniques selected according to predetermined criteria of eligibility and observed for predefined evidence of favorable and unfavorable effects. This concept includes clinical trials conducted both in the U.S. and in other countries.
| Descriptor ID |
D002986
|
| MeSH Number(s) |
E05.318.760.250.500 N05.715.360.775.088.500 N06.850.520.450.250.250
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Clinical Trials as Topic".
Below are MeSH descriptors whose meaning is more specific than "Clinical Trials as Topic".
This graph shows the total number of publications written about "Clinical Trials as Topic" by people in this website by year, and whether "Clinical Trials as Topic" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1995 | 5 | 20 | 25 |
| 1996 | 1 | 20 | 21 |
| 1997 | 0 | 29 | 29 |
| 1998 | 3 | 29 | 32 |
| 1999 | 5 | 28 | 33 |
| 2000 | 7 | 41 | 48 |
| 2001 | 4 | 61 | 65 |
| 2002 | 11 | 75 | 86 |
| 2003 | 8 | 85 | 93 |
| 2004 | 5 | 77 | 82 |
| 2005 | 12 | 68 | 80 |
| 2006 | 23 | 91 | 114 |
| 2007 | 19 | 90 | 109 |
| 2008 | 18 | 99 | 117 |
| 2009 | 24 | 103 | 127 |
| 2010 | 23 | 107 | 130 |
| 2011 | 30 | 103 | 133 |
| 2012 | 20 | 77 | 97 |
| 2013 | 20 | 67 | 87 |
| 2014 | 28 | 72 | 100 |
| 2015 | 24 | 71 | 95 |
| 2016 | 30 | 92 | 122 |
| 2017 | 22 | 79 | 101 |
| 2018 | 29 | 63 | 92 |
| 2019 | 31 | 57 | 88 |
| 2020 | 30 | 73 | 103 |
| 2021 | 19 | 54 | 73 |
| 2022 | 6 | 26 | 32 |
| 2023 | 5 | 25 | 30 |
| 2024 | 24 | 25 | 49 |
| 2025 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Clinical Trials as Topic" by people in Profiles.
-
Combining Biology-based and MRI Data-driven Modeling to Predict Response to Neoadjuvant Chemotherapy in Patients with Triple-Negative Breast Cancer. Radiol Artif Intell. 2025 Jan; 7(1):e240124.
-
International workshop: what is needed to ensure outcome measures for Rett syndrome are fit-for-purpose for clinical trials? June 7, 2023, Nashville, USA. Trials. 2024 Dec 21; 25(1):845.
-
Targeted radionuclide therapy for gliomas: Emerging clinical trial landscape. Neuro Oncol. 2024 Dec 09; 26(Supplement_9):S208-S214.
-
Next-generation combination approaches for immune checkpoint therapy. Nat Immunol. 2024 Dec; 25(12):2186-2199.
-
The future of hypertension pharmacotherapy: Ongoing and future clinical trials for hypertension. Curr Probl Cardiol. 2025 Jan; 50(1):102922.
-
Optimizing early phase clinical trial washout periods: a report from the Therapeutic Advances in Childhood Leukemia and Lymphoma consortium. J Natl Cancer Inst. 2024 Nov 01; 116(11):1721-1729.
-
Patient-reported outcomes in early phase trials for patients with myelodysplastic syndromes. Semin Hematol. 2024 Dec; 61(6):457-464.
-
Safety and tolerability of mirvetuximab soravtansine monotherapy for folate receptor alpha-expressing recurrent ovarian cancer: An integrated safety summary. Gynecol Oncol. 2024 Dec; 191:249-258.
-
Comparison of targeted web-based advertising versus traditional methods for recruiting older adults into clinical trials. J Am Geriatr Soc. 2025 Jan; 73(1):182-192.
-
Challenges and opportunities for early phase clinical trials of novel drug-radiotherapy combinations: recommendations from NRG Oncology, the American Society for Radiation Oncology (ASTRO), the American College of Radiology (ACR), the Sarah Cannon Research Institute, and the American College of Radiation Oncology (ACRO). Lancet Oncol. 2024 Oct; 25(10):e489-e500.